A protein-protein interaction network of transcription factors acting during liver cell proliferation

Genomics

Volumn 91, Issue 4, 2008, Pages 347-355

  Gao, Jin ^a   Li, Wen Xi ^a   Feng, Si Qian ^b   Yuan, Yun Sheng ^a   Wan, Da Fang ^a   Han, Wei ^a   Yu, Yan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

Cell proliferation; Liver regeneration; Matrix mating Y2H assay; Protein protein interaction; Transcription factor

Indexed keywords

GLUTATHIONE TRANSFERASE ALPHA; TRANSCRIPTION FACTOR;

ARTICLE; DRUG TARGETING; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIVER DISEASE; LIVER INJURY; LIVER REGENERATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

CELL PROLIFERATION; DNA, COMPLEMENTARY; ESCHERICHIA COLI; HUMANS; LIVER; PROTEIN BINDING; TRANSCRIPTION FACTORS;

MUS;

EID: 41049100060     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2007.12.007     Document Type: Article

References (40)

1. Chrunyk B.A., et al. Inhibiting protein-protein interactions: a model for antagonist design. Biochemistry 39 (2000) 7092-7099
2. Jang H., et al. Finding the evidence for protein-protein interactions from PubMed abstracts. Bioinformatics 22 (2006) e220-e226
3. Uetz P., et al. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 403 (2000) 623-627
4. Giot L., et al. A protein interaction map of Drosophila melanogaster. Science 302 (2003) 1727-1736
5. Li S.M., et al. A map of the interactome network of the metazoan Caenorhabditis elegans. Science 303 (2004) 540-543
6. Stelzl U., et al. A human protein-protein interaction network: a resource for annotating the proteome. Cell 122 (2005) 957-968
7. Rual J., et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature 437 (2005) 1173-1178
8. Ewing R.M., et al. Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol. Syst. Biol. 89 (2007)
9. Fields S., and Song O. A novel genetic system to detect protein-protein interaction. Nature 340 (1989) 245-247
10. Chien C.T., Bartel P.L., Sternglanz R., and Fields S. The two-hybrid system: a method to identify and clone genes for proteins that interact with a protein of interest. Proc. Natl. Acad. Sci. U. S. A. 8 (1991) 9578-9582
11. Michalopoulos G.K., and DeFrance M.C. Liver regeneration. Science 278 (1997) 60-65
12. Taub R. Liver regeneration: from myth to mechanism. Nature 5 (2004) 836-847
13. Fausto N., Campbell J.S., and Riehle K.J. Liver regeneration. Hepatology 43 (2006) s45-s53
14. Wan D.F., et al. Large-scale cDNA transfection screening for genes related to cancer development and progression. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 15724-15729
15. Lehner B., and Sanderson C.M. A protein interaction framework for human mRNA degradation. Genome Res. 14 (2004) 1315-1323
16. Chu H.M., Tan Y., Kobierski L.A., Balsam L.B., and Comb M.J. Activating transcription factor-3 stimulates 3′, 5′-cyclic adenosine monophosphate-dependent gene expression. Mol. Endocrinol. 8 (1994) 59-68
17. Wibley J., Deed R., Jasiok M., Douglas K., and Norton J. A homology model of the Id-3 helix-loop-helix domain as a basis for structure-function predictions. Biochim. Biophys. Acta 1294 (1996) 138-146
18. Wixler V., et al. The LIM-only protein DRAL/FHL2 binds to the cytoplasmic domain of several alpha and beta integrin chains and is recruited to adhesion complexes. J. Biol. Chem. 275 (2000) 33669-33678
19. Johannessen M., Møller S., Hansen T., Moens U., and Van Ghelue M. The multifunctional roles of the four-and-a-half-LIM only protein FHL2. Cell. Mol. Life Sci. 63 (2006) 268-284
20. Amaar Y.G., et al. Insulin-like growth factor-binding protein 5 (IGFBP-5) interacts with a four and a half LIM protein 2 (FHL2). J. Biol. Chem. 277 (2002) 12053-12060
21. Li H.Y., et al. Protein-protein interaction of FHL3 with FHL2 and visualization of their interaction by green fluorescent proteins (GFP) two-fusion fluorescence resonance energy transfer (FRET). J. Cell Biochem. 80 (2001) 293-303
22. Pahlavan P.S., Feldmann R.E., Zavos C., and Kountouras J. Prometheus' challenge: molecular, cellular and systemic aspects of liver regeneration. J. Surg. Res. 134 (2006) 238-251
23. Chen B.P.C., Liang G., Whelan J., and Hai T. ATF3 and ATF3δZip. J. Biol. Chem. 269 (1994) 15819-15826
24. Hashimoto Y., et al. An alternatively spliced isoform of transcriptional repressor ATF3 and its induction by stress stimuli. Nucleic Acids Res. 30 (2002) 2398-2406
25. Cai Y., et al. Homocysteine-responsive ATF3 gene expression in human vascular endothelial cells: activation of c-Jun NH2-terminal kinase and promoter response element. Blood 96 (2000) 2140-2148
26. Ishiguro T., Nakajima M., Naito M., Muto T., and Tsuruo T. Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials. Cancer Res. 56 (1996) 875-879
27. Iyengar P., et al. Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization. Oncogene 22 (2003) 6408-6423
28. Ishiguro T., Nagawa H., Naito M., and Tsuruo T. Inhibitory effect of ATF3 antisense oligonucleotide on ectopic growth of HT29 human colon cancer cells. Jpn. J. Cancer Res. 91 (2000) 833-836
29. Lu D., Wolfgang C.D., and Hai T. Activating transcription factor 3, a stress-inducible gene, suppresses ras-stimulated tumorigenesis. J. Biol. Chem. 281 (2006) 10473-10481
30. Fan F., et al. ATF3 induction following DNA damage is regulated by distinct signaling pathways and over-expression of ATF3 protein suppresses cells growth. Oncogene 21 (2002) 7488-7496
31. Allan A.L., Albanese C., Pestell R.G., and LaMarre J. Activating transcription factor 3 induces DNA synthesis and expression of cyclin D1 in hepatocytes. J. Biol. Chem. 276 (2001) 27272-27280
32. Yan C., Lu D., Hai T., and Boyd D.D. Activating transcription factor 3, a stress sensor, activates p53 by blocking its ubiquitination. EMBO J. 24 (2005) 2425-2434
33. Yan C., Wang H., and Boyd D.D. ATF3 represses 72-kDa type IV collagenase (MMP-2) expression by antagonizing p53-dependent trans-activation of the collagenase promoter. J. Biol. Chem. 277 (2002) 10804-10812
34. Lin K.I., DiDonato J.A., Hoffmann A., Hardwick J.M., and Ratan R.R. Suppression of steady-state, but not stimulus-induced NF-kappaB activity inhibits alphavirus-induced apoptosis. J. Biol. Chem. 141 (1998) 1479-1487
35. C.E. Canman, T.M. Gilmer, S.B. Coutts, M.B. Kastan, Growth factor modulation of p53-mediated growth arrest versus apoptosis, Genes Dev. 9 (9) 600-611.
36. Schwartz D., and Rotter V. p53-dependent cell cycle control: response to genotoxic stress. Semin. Cancer Biol. 8 (1998) 325-336
37. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 88 (1997) 323-331
38. Roberts A.B., and Wakefield L.M. The two faces of transforming growth factor beta in carcinogenesis. Proc. Natl. Acad. Sci. USA 100 (2003) 8430-8435
39. Hsu J.C., Laz T., Mohn K.L., and Taub R. Identification of LRF-1, a leucine-zipper protein that is rapidly and highly induced in regenerating liver. Proc. Natl. Acad. Sci. USA 88 (1991) 3511-3515
40. Chu H.M., Tan Y., Kobierski L.A., Balsam L.B., and Comb M.J. Activating transcription factor-3 stimulates 3′, 5′-cyclic adenosine monophosphate-dependent gene expression. Mol. Endocrinol. 8 (1994) 59-68